Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Andersen

Showing results (51-60 of 197) with videos related to

Pageof 20
Sort By:
Expert Opinion on Drug Safety|January 7, 2020
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazineMaurizio Sessa, Annamaria Mascolo, Kim Peder Dalhoff, et al.
Scandinavian Journal of Primary Health Care|July 30, 2020
Drug-disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension - a population-based registry studyKatharina Schmidt-Mende, Morten Andersen, Björn Wettermark, et al.
Schizophrenia Research|October 11, 2011
Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorderRobert Bodén, Lena Brandt, Helle Kieler, et al.
British Journal of Clinical Pharmacology|October 13, 2016
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysisJoris Komen, Tomas Forslund, Paul Hjemdahl, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control studyJesper Hallas, Rene Christensen, Morten Andersen, et al.
Journal of Pain and Symptom Management|April 29, 2005
Use of opioids in a Danish population-based cohort of cancer patientsLene Jarlbaek, Morten Andersen, Jesper Hallas, et al.
European Journal of Clinical Pharmacology|March 31, 2020
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medicationDiana M Rydberg, Marie Linder, Rickard E Malmström, et al.
Journal of Theoretical Biology|February 15, 2021
Mathematical modelling of the hematopoietic stem cell-niche system: Clonal dominance based on stem cell fitnessRasmus Kristoffer Pedersen, Morten Andersen, Thomas Stiehl, et al.
Drug Safety|September 9, 2021
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare DataMia Aakjær, Marie Louise De Bruin, Murat Kulahci, et al.
Lancet (London, England)|August 23, 2003
Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological databaseHenrik Støvring, Morten Andersen, Henning Beck-Nielsen, et al.
Pageof 20

Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Safety|January 7, 2020
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazineMaurizio Sessa, Annamaria Mascolo, Kim Peder Dalhoff, et al.
Scandinavian Journal of Primary Health Care|July 30, 2020
Drug-disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension - a population-based registry studyKatharina Schmidt-Mende, Morten Andersen, Björn Wettermark, et al.
Schizophrenia Research|October 11, 2011
Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorderRobert Bodén, Lena Brandt, Helle Kieler, et al.
British Journal of Clinical Pharmacology|October 13, 2016
Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysisJoris Komen, Tomas Forslund, Paul Hjemdahl, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control studyJesper Hallas, Rene Christensen, Morten Andersen, et al.
Journal of Pain and Symptom Management|April 29, 2005
Use of opioids in a Danish population-based cohort of cancer patientsLene Jarlbaek, Morten Andersen, Jesper Hallas, et al.
European Journal of Clinical Pharmacology|March 31, 2020
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medicationDiana M Rydberg, Marie Linder, Rickard E Malmström, et al.
Journal of Theoretical Biology|February 15, 2021
Mathematical modelling of the hematopoietic stem cell-niche system: Clonal dominance based on stem cell fitnessRasmus Kristoffer Pedersen, Morten Andersen, Thomas Stiehl, et al.
Drug Safety|September 9, 2021
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare DataMia Aakjær, Marie Louise De Bruin, Murat Kulahci, et al.
Lancet (London, England)|August 23, 2003
Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological databaseHenrik Støvring, Morten Andersen, Henning Beck-Nielsen, et al.
Pageof 20